Collagen density promotes mammary tumor initiation and progression by Provenzano, Paolo P et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Medicine
Open Access Research article
Collagen density promotes mammary tumor initiation and 
progression
Paolo P Provenzano*1,2,3, David R Inman1,3, Kevin W Eliceiri2, 
Justin G Knittel1, Long Yan2, Curtis T Rueden2, John G White2 and 
Patricia J Keely*1,2,3
Address: 1Department of Pharmacology, University of Wisconsin, Madison, WI 53706, USA, 2Molecular Biology Program, Laboratory for Optical 
and Computational Instrumentation, University of Wisconsin, Madison, WI 53706, USA and 3University of Wisconsin Paul P. Carbone 
Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53706, USA
Email: Paolo P Provenzano* - ppproven@wisc.edu; David R Inman - drinman@wisc.edu; Kevin W Eliceiri - eliceiri@wisc.edu; 
Justin G Knittel - justin.knittel@case.edu; Long Yan - longyan@wisc.edu; Curtis T Rueden - ctrueden@wisc.edu; 
John G White - jwhite1@wisc.edu; Patricia J Keely* - pjkeely@wisc.edu
* Corresponding authors    
Abstract
Background: Mammographically dense breast tissue is one of the greatest risk factors for developing breast
carcinoma. Despite the strong clinical correlation, breast density has not been causally linked to tumorigenesis,
largely because no animal model has existed for studying breast tissue density. Importantly, regions of high breast
density are associated with increased stromal collagen. Thus, the influence of the extracellular matrix on breast
carcinoma development and the underlying molecular mechanisms are not understood.
Methods: To study the effects of collagen density on mammary tumor formation and progression, we utilized a
bi-transgenic tumor model with increased stromal collagen in mouse mammary tissue. Imaging of the tumors and
tumor-stromal interface in live tumor tissue was performed with multiphoton laser-scanning microscopy to
generate multiphoton excitation and spectrally resolved fluorescent lifetimes of endogenous fluorophores.
Second harmonic generation was utilized to image stromal collagen.
Results: Herein we demonstrate that increased stromal collagen in mouse mammary tissue significantly increases
tumor formation approximately three-fold (p < 0.00001) and results in a significantly more invasive phenotype
with approximately three times more lung metastasis (p < 0.05). Furthermore, the increased invasive phenotype
of tumor cells that arose within collagen-dense mammary tissues remains after tumor explants are cultured within
reconstituted three-dimensional collagen gels. To better understand this behavior we imaged live tumors using
nonlinear optical imaging approaches to demonstrate that local invasion is facilitated by stromal collagen re-
organization and that this behavior is significantly increased in collagen-dense tissues. In addition, using
multiphoton fluorescence and spectral lifetime imaging we identify a metabolic signature for flavin adenine
dinucleotide, with increased fluorescent intensity and lifetime, in invading metastatic cells.
Conclusion: This study provides the first data causally linking increased stromal collagen to mammary tumor
formation and metastasis, and demonstrates that fundamental differences arise and persist in epithelial tumor cells
that progressed within collagen-dense microenvironments. Furthermore, the imaging techniques and signature
identified in this work may provide useful diagnostic tools to rapidly assess fresh tissue biopsies.
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Background
Mammographically dense breast tissue is linked to a
greater than four-fold increased risk of breast carcinoma
[1-3], and is one of the greatest independent risk factors
for breast cancer [1,2,4]. For instance, breast density in
more than 50% of the tissue may account for up to 30%
of breast cancers, while BRCA1 and BRCA2 mutations,
although conferring a greater relative risk, account for
only 5% of breast cancers (see Boyd et al [5] and refer-
ences therein). Breast tissue density is additionally
increased with hormone replacement therapy [6], suggest-
ing increased density may be part of the underlying mech-
anism by which hormone replacement therapy increases
cancer risk. Furthermore, ductal carcinoma in situ (DCIS),
a local precursor to some invasive breast cancers, arises
overwhelmingly in dense regions of the breast [7]; and
high breast tissue density is associated with a shift to more
malignant tumors [8], an increased likelihood of DCIS
[8,9], invasive breast carcinoma [9,10], lymphatic and
vascular invasion [11], and an approximately three-fold
greater risk of developing a second breast carcinoma [10].
However, although there is considerable correlative data
identifying breast density as a risk factor for developing
carcinoma, a causal link between breast density and carci-
noma has not been established. Moreover, the molecular
mechanisms driving breast density-related tumor forma-
tion and progression remain largely unknown.
Importantly, areas of increased breast density are not only
associated with increased epithelial and stromal cellular-
ity [12-14], but also significantly increased fibrillar colla-
gen deposition [8,13,14]. In addition, it has been reported
that levels of total collagen increase as radiographic breast
tissue density increases [8,13]. This is significant since tis-
sue microenvironments play an important role in main-
taining normal cellular behavior [15,16], and stroma
surrounding breast epithelial cells is believed to be criti-
cally involved in epithelial transformation, carcinoma
growth, and metastasis [17-21]. Consistent with this con-
cept, adipose-derived type VI collagen promotes tumor
growth [22], while disturbing the epithelial-stromal inter-
action by disrupting the β1-integrin in mammary epithe-
lial cells inhibits tumorigenesis [23]. A less considered
aspect of the complexity of the epithelial-stromal interac-
tion is the fact that the stroma is a dynamic mechanical
microenvironment, with dense collagenous stroma trans-
mitting multi-axial deformations to breast cells during tis-
sue deformation and increasing resistance to cellular
contractility. Such mechanical signals arising from
increased density or rigidity of the microenvironment
play a role in the transformed phenotype of breast epithe-
lial cells [24,25]. Hence, although tumor formation is a
multistep process involving genetic alterations of the epi-
thelial cell, it has become clear that the epithelial-stromal
interaction plays a crucial role in tumor formation and
progression. Therefore, due to the increased stroma asso-
ciated with breast tissue density we hypothesized that
increasing collagen density in the mammary gland would
promote tumorigenesis. Although there is a strong correl-
ative link between breast density and carcinoma, to date
collagen density has not been causally linked to tumori-
genesis, largely because studies utilizing animal models
with different stromal density have not been performed
previously. Here we demonstrate that mammary tumor
formation, invasion, and metastasis are enhanced in col-
lagen-dense stroma in a transgenic mouse model.
Methods
Mice
The University of Wisconsin animal use and care commit-
tee approved this study. Breeding pairs of Col1a1tmJae mice
[26] in the B6/129 background were obtained from Jack-
son Laboratory. Male FVB Polyomavirus middle-T mice
under the control of the mammary specific MMTV pro-
moter were originally obtained from Dr Amy Moser (Uni-
versity of Wisconsin) and are abbreviated PyVT following
the Jackson Laboratory (from which they originated)
nomenclature, but are also commonly abbreviated as
PyMT or PyV MT. Col1a1tmJae homozygote males were
crossed to C57BL/6 females to generate heterozygous
females that were crossed to PyVT males to generate mice
with normal and collagen-dense mammary tissues carry-
ing the polyoma transgene. Mice were palpated every 2 to
3 days starting at 8 weeks of age to identify tumors. Gen-
otyping by polymerase chain reaction (PCR) was per-
formed on DNA extracted from tail biopsies (Wizard SV
Genomic DNA Purification System, Promega, Madison,
WI) using primers indicated in the strain information pro-
vided by The Jackson Laboratory. Mice were examined for
palpable tumors starting at eight weeks of age and
humanely killed at 15 weeks or when the tumor burden
became excessive.
Histology and mammary gland whole mounts
Selected mammary tissues and tumors were fixed in 4%
paraformaldehyde in phosphate buffered saline (PBS)
and then embedded in paraffin. In addition, all tissues
imaged with multiphoton microscopy were subsequently
fixed and processed for histology. Tissue sections were
stained with hematoxylin and eosin (H&E) with adjacent
sections stained with the selective collagen stain, picrosir-
ius red. Mammary whole mounts were prepared by fixing
tissues in Carnoy's solution (10% glacial acetic acid, 30%
chloroform, and 60% absolute ethanol), followed by
rehydration and staining with carmine alum. Tissues were
then dehydrated, cleared with xylene, and mounted.
Immunofluorescence
Immunofluorescent staining of mammary epithelial cells
was performed in a manner similar to the methodologyBMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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described by Wozniak and co-workers [25]. Briefly, colla-
gen gels were fixed in 4% paraformaldehyde for 20 min-
utes at room temperature. Following three washes in PBS,
paraformaldehyde fluorescence was quenched with 0.15
M glycine in PBS then the gels were washed with PBS. Tri-
ton-X (0.2%) was added to permeabalize the cells, and
gels blocked overnight with 2.5% fatty acid-free bovine
serum albumin (BSA) + 1% donkey serum. Cell prolifera-
tion was then examined by staining with the anti-Ki-67
(mouse clone 7B11; Zymed) primary antibody in PBS
containing 1% donkey serum for 30 minutes at room
temperature. Following five 10-minute washes in PBS,
gels were incubated with anti-mouse tetramethylrhodam-
ine isothiocyanate (TRITC; Jackson ImmunoResearch
Laboratories) secondary antibody, phalloidin-fluorescein
isothiocyanate (FITC; Jackson ImmunoResearch Labora-
tories), and bisbenzimide (Sigma-Aldrich) in PBS con-
taining 1% donkey serum for 30 minutes at room
temperature. Gels were again washed with PBS and
mounted with Prolong Antifade mounting media (Molec-
ular Probes). Imaging was performed on a TE300 Nikon
epifluorescence inverted microscope with acquired z-
stacks deconvolved using Slidebook imaging software
(Olympus).
Lung metastasis
Lungs from PyVT/wt (n = 4) and PyVT/Col1a1 (n = 4)
mice (as well as wt/wt and wt/Col1a1 as negative con-
trols) were harvested at 15 weeks, fixed in formalin, and
processed for histology. Sections were cut every 50 µm
through the entire tissue and sections stained with H&E.
Total lung metastases over all sections were then counted.
Three-dimensional invasion assay
Uniform sized tumor explants were harvested from intact
tumors using a tissue biopsy punch (3 mm diameter),
rinsed with PBS (containing 100 units penicillin, 100 µg
streptomycin, and 0.25 µg/ml amphotericin B), and
placed into 2.0 mg/ml collagen gels (BD Biosciences, San
Diego, CA) that were neutralized with 2× HEPES buffer.
Tumors were maintained in collagen gels floated in Dul-
becco's Modified Eagle's Medium (DMEM) containing
5% fetal bovine serum (FBS), penicillin (100 units), strep-
tomycin (100 µg), and amphotericin B (0.25 µg/ml) for
10 days over which time the number of distant multicel-
lular colonies were counted.
Isolation of tumor cells and migration assay
Tumors from PyVT/wt and PyVT/Col1a1 backgrounds
were minced and digested with 2 mg/ml collagenase and
10 µg/ml hyaluronidase in DMEM containing penicillin
(100 units), streptomycin (100 µg), and amphotericin B
(0.25  µg/ml). Following gentle shaking at 37°C for 3
hours, cells were pelleted, washed, and plated in DMEM
containing 5% FBS. Thirty-six hours post-harvest the
tumor cells were transferred to Transwell plates (Corning
Inc, Corning, NY) using serum and soluble collagen con-
taining media as the chemoattractant.
Multiphoton laser-scanning microscopy
For live tissue imaging by multiphoton excitation (MPE)
and second harmonic generation (SHG), mammary
tumors were harvested and live tissue maintained in buff-
ered media at 37°C. All tissues were imaged immediately
following tissue harvest using an Optical Workstation
[27] that was constructed around a Nikon Eclipse TE300.
A Tsunami Ti:sapphire laser driven by a Millenia 5 W
pump laser (Spectra Physics, Mountain View, CA) excita-
tion source producing around 100 fs pulse widths and
tuned to 890 nm was utilized to generate both MPE and
SHG. The beam was focused onto the sample with a
Nikon 60X Plan Apo water-immersion lens (numerical
aperture (NA) = 1.2). All SHG imaging was detected from
the back-scattered SHG signal [28], and the presence of
collagen confirmed in our tissues using fluorescence life-
time imaging microscopy (FLIM) on the same optical
workstation, since the SHG from collagen has no lifetime.
Furthermore, owing to the fundamentally different physi-
cal behavior of MPE and SHG, signals could be discrimi-
nated by filtering the emission signal. We used a 464 nm
(cut-on) long pass filter to isolate the emission from
autofluorescence from the conserved 445 nm SHG emis-
sion. A 445 nm (narrow-band pass) filter was therefore
used to isolate the SHG emission. Acquisition was per-
formed with WiscScan [29] a software acquisition package
developed at LOCI (Laboratory for Optical and Computa-
tional Instrumentation, University of Wisconsin, Madi-
son, WI) and image analysis for MPE/SHG was performed
with ImageJ and VisBio [30] software. For TACS-1 image
analysis, additional surface rendering plug-ins for ImageJ
were utilized [31]. For TACS-2 and -3, ImageJ was used to
quantify the collagen fiber angle relative to the tumor. The
tumor boundary was defined and the angle relative to the
tangent of tumor boundary was measured every 10 µm as
reported previously [27].
Fluorescence and spectral lifetime imaging microscopy
FLIM was performed on live tissue with the optical work-
station described above and as described previously [27].
Briefly, the Ti:sapphire laser (Millennium/Tsunami, Spec-
tra-Physics, Mountain View, CA) was tuned to 890 nm
with the beam focused onto the sample with a Nikon 60X
Plan Apo water-immersion lens (NA = 1.2). Intensity and
FLIM data were collected by a H7422 GaAsP photon-
counting photomultiplier tube (PMT; Hamamatsu,
Bridgewater, NJ) connected to a time-correlated single
photon counting (TCSPC) system (SPC-730, Becker &
Hickl, Berlin, Germany). Multiphoton spectral lifetime
imaging microscopy (SLIM) was performed using a sec-
ond-generation system that evolved from a previouslyBMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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described instrument [32] built around an inverted micro-
scope (Eclipse TE2000, Nikon, Melville, NY). Briefly, a
Mira Ti:sapphire mode-locking laser driven by a Verdi 8 W
laser (Coherent Mira, Coherent, Santa Clara, CA) was
used to generate pulse widths of approximately 120 fs at a
repetition rate of 76 MHz. Intensity and fluorescence life-
time data were collected over 16 individual 10 nm spec-
tral-width channels using a 16-anode photon counting
linear PMT array (PML-16, Becker & Hickl) connected to a
TCSPC system (SPC-830, Becker&Hickl). Fluorescent life-
time analysis from FLIM and SLIM was carried out with
SPCImage (Becker & Hickl) as well as with a LOCI created
computational tool, SlimPlotter [33], which allows visu-
alization and analysis of the lifetimes by spectral channel.
Statistical analysis
For multi-group comparisons, one-way analysis of vari-
ance (ANOVA) with a post-hoc  Tukey-Kramer test was
used. We performed t-testing for two-group comparisons.
Results
Increased collagen density promotes mammary epithelial 
cell proliferation in reconstituted three-dimensional 
matrices
To test the hypothesis that increased collagen density can
directly promote growth of mammary epithelial cells in
the absence of stromal cells, human MCF10A cells were
cultured within three-dimensional collagen gels and pro-
liferation was measured (Figure 1). Cells cultured within
low-density matrices form well-differentiated acini struc-
tures, while colonies that formed within high-density
matrices are larger, less-organized structures (Figure 1a).
In agreement with the formation of larger colonies, prolif-
eration of human mammary epithelial cells is increased in
high-density matrices (Figure 1b), indicating that increas-
ing collagen matrix density can directly promote epithe-
lial cell proliferation.
Increased tumor incidence in collagen-dense mammary 
tissues
In order to develop a murine tumor model possessing col-
lagen-dense mammary tissue, we examined the mammary
tissues from Col1a1tmJae  transgenic mice (Figure 2a).
These mice carry mutations near the highly conserved
matrix metalloproteinase (MMP) cleavage site for type I
collagen (between Gly775 and Ile776 of the α1(I) chain)
that make the collagen resistant to human collagenase
digestion [26]. Although an additional cleavage site on
type I collagen is vulnerable to rodent collagenase (often
termed rat collagenase) and the collagen is susceptible to
other proteases [26], these are not sufficient to achieve the
proper balance of collagen synthesis and degradation,
resulting in excessive collagen accumulation in the skin,
uterus, and bone [26]. These phenotypes raised the possi-
bility that the mammary gland, which undergoes dynamic
changes in collagen deposition and degradation during
development, puberty, and estrous, would rapidly accu-
mulate excess stromal collagen. To explore this possibil-
ity, we previously analyzed mammary glands from wild-
type, heterozygous, and homozygous Col1a1tmJae mice.
Using techniques specific for collagen detection, we
reported a greater than 2.5-fold increase in stromal colla-
gen associated with heterozygous or homozygous mice
when compared with wild-type mice [27] (Figure 2a).
With a defined model for breast tissue density in place, we
set out to test the hypothesis that increased mammary col-
lagen density increases tumor formation. Mammary
tumors were initiated with the PyVT transgene. This breast
tumor model correlates well with many features of human
Increased collagen matrix density directly promotes epithelial cell proliferation Figure 1
Increased collagen matrix density directly promotes epithelial cell proliferation. (a) Actin staining to visualize 
MCF10A human mammary epithelial cells cultured within low (1.3 mg/ml) and high-density (3.0 mg/ml) collagen gels for 21 days 
(actin, green; nuclei, blue). Left: Two well-differentiated acini structures formed in low-density matrices. Right: A single, less-
organized colony. (b) Increased proliferation of mammary epithelial cells cultured within high-density matrices, measured by 
increased detection of the Ki67 antigen, a marker of proliferation.BMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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cancer, progresses from hyperplasia to adenoma to early
and late carcinoma [34], and is reliably invasive and met-
astatic [34]. When mice carrying the PyVT transgene under
the control of the mammary epithelial-specific MMTV
promoter were crossed with heterozygous Col1a1tmJae
mice, we observed an approximately three-fold increase in
early tumor formation in collagen-dense tissues (that is, a
three-fold greater number of tumors per mouse; see Figure
2b). This trend of increased tumor incidence in collagen-
dense glands continued through week 15 (Figure 2b), and
High mammary collagen density promotes tumor formation Figure 2
High mammary collagen density promotes tumor formation. (a) Histology of mammary glands from 10-week-old 
wild-type and heterozygous Col1a1tmJae mice showing increased stromal collagen and hypercellularity associated with the 
Col1a1tmJae mouse model. Scale bar 25 µm. (b) Significantly increased tumor numbers per mouse in collagen-dense (Col1a1) 
mammary glands. (c) Whole mount preparations of the fourth inguinal mammary glands from PyVT/wt and PyVT/Col1a1 mice 
at 10 weeks of age. Quantitative analysis of the area of hyperplasia from three pairs of glands calculated from a common 
threshold value set with density slicing in ImageJ software revealed a greater than 1.5-fold increase in hyperplasia associated 
with increased stromal collagen (t-test: p = 0.03). In addition, at age-matched time points, tumors in mice with dense stroma 
not only displayed more hyperplastic area but also tumor regions that grew out away from the gland (arrows in (c) and (d)). 
(e) Low (i), (ii) and high (iii), (iv) magnification images of H&E stained histology sections from 10-week-old mice showing 
increased collagen in PyVT/Col1a1 tumors ((ii) and (iv)) and a more invasive phenotype when compared with PyVT/wt (i) and 
(iii) tumors. Scale bars 50 µm in (i) and (ii) and 25 µm in (iii) and (iv).BMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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two additional PyVT/Col1a1 mice needed to be eutha-
nized by week 13 due to excessive tumor burden (not
shown). Consistent with these observations, quantitative
analysis of whole mounts of the fourth mammary gland
(n = 3 pairs) show significantly increased areas of hyper-
plasia (Figure 2c) with collagen-dense tissues showing
increased cell growth out from the gland (Figure 2c arrow-
head and Figure 2d). Furthermore, tumors progressing in
collagen-dense tissues at 10 weeks had a more invasive
morphology (Figure 2e). Of note is the fact that tumors
arising in collagen-dense mammary tissue retain
increased collagen density (Figure 2e and confirmed with
collagen selective picrosirius red staining (not shown)). In
fact, collagen levels in PyVT/Col1a1 tumor-bearing glands
appear to be increased relative to non-tumor bearing col-
lagen-dense glands (Figure 2e). This observation possibly
indicates an amplified shift in the imbalance between col-
lagen synthesis and degradation in the Col1a1 mice fol-
lowing tumor initiation, and may represent an increased
desmoplastic response.
Increased invasion and metastasis associated with dense 
stromal collagen
Examination of later-stage tumors (week 15) demon-
strated that both PyVT/wt and PyVT/Col1a1 tumors were
invasive (data not shown), confirming an earlier report
that late-stage wild-type PyVT tumors have invasiveness
associated with collagen reorganization [27]. Moreover,
since the MMTV-PyVT tumor model reliably results in
lung metastases, we examined lung tissue in late-stage
mice (week 15). In animals in which tumors were initi-
ated and progressed in a collagen-dense microenviron-
ment, a significant increase in the number of lung
metastases was observed (Figure 3a). This raised the pos-
sibility that increased lung metastasis may be the result of
a more-invasive and migratory cell population, or may
result from the earlier onset of invasiveness. To address
this question, we isolated tumor plugs and tumor cells
and performed invasion and migration assays, respec-
tively.
Data showing increased invasion in tumors that arose in
collagen-dense tissue was obtained by quantifying inva-
sion from tumor explants into three-dimensional colla-
gen gels. To determine whether local invasion was a
simple reflection of increased local collagen that facilitates
invasion or also due to an intrinsic property of tumor cells
arising in a collagen-dense stroma, tumor explants of
defined size were placed into three-dimensional collagen
gels and the number of distant colonies was counted.
After 10 days in culture, explants from collagen-dense tis-
sues resulted in significantly more colonies (Figure 3b).
Furthermore, tumor cells isolated from collagen-dense tis-
sues were in fact more migratory (Figure 3c), indicating
that the earlier onset of invasiveness is likely not the sole
cause for increased metastasis but that the tumor cells
themselves are more invasive (Figure 3b) and migratory
(Figure 3c).
Changes in the tumor-stromal interaction associated with 
increased stromal collagen
Collagen content, fiber structure, and organization are
potentially key determinants of tumor cell behavior
[27,35]. Therefore, to better understand the reported
Increased metastasis associated with dense stromal collagen Figure 3
Increased metastasis associated with dense stromal collagen. (a) Increased number of lung metastases per lung at 15 
weeks in mice that formed tumors in collagen-dense mammary glands (PyVT/Col1a1) when compared with mice that formed 
tumors in control glands (PyVT/wt; mean ± standard error of the mean (SEM), n = 4 of each genotype). (b) Three-dimensional 
tumor cell invasion assay showing that tumor explants from collagen-dense tumors (PyVT/Col1a1) resulted in more invasion 
into three-dimensional collagen gels and colony formation after 10 days than explants from PyVT/wt tumors (mean ± SEM; n = 
4 PyVT/wt and n = 14 PyVT/Col1a1 tumor explants from four sibling mice). (c) Tumor cells extracted from collagen-dense 
tumors (PyVT/Col1a1) showed increased migration when compared to tumor cells from control tumors (PyVT/wt) as meas-
ured by transwell migration assays with serum as the chemoattractant (mean ± SEM; n ≥ 3 independent experiments). *Indi-
cates a statistically significant difference (p < 0.05) following analysis with t-tests.BMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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increase in invasion and metastasis associated with
increased collagen density, we employed nonlinear opti-
cal imaging of tumor-stromal interactions in intact live
tumors. Multiphoton laser-scanning microscopy
(MPLSM) was used to simultaneously generate intrinsic
signals from cellular autofluorescence by MPE and fibril-
lar collagen by SHG [27,36-38]. Using this approach we
previously defined [27] three Tumor-Associated Collagen
Signatures (TACS; Figure 4) in mammary tumors from
both Wnt-1 and PyVT transgenic mice. Specifically: TACS-
1, the presence of locally dense collagen (Figure 4a)
within the globally increased collagen concentration sur-
rounding tumors, indicated by increased signal intensity
(Figure 4c) at a region near the tumor, which serves as a
reliable hallmark for locating small tumor regions (Figure
4b); TACS-2, straightened (taut) collagen fibers stretched
around the tumor, constraining the tumor volume (Figure
4d and 4e); and TACS-3, identification of radially aligned
collagen fibers that facilitate local invasion (Figure 4f).
With TACS-3, a distribution of collagen fiber angles
around 90° relative to the tumor boundary was indicative
of high levels of local invasion while a distribution
Tumor-associated collagen signatures Figure 4
Tumor-associated collagen signatures. (a)-(c) Example of TACS-1. A region of locally dense collagen (a) near (40 µm 
'above') a small tumor region (b) that is within the globally increased collagen region surrounding tumors, resulting from 
increased SHG (collagen) signal intensity; (c) three-dimensional surface plot of intensity  showing an approximately three-fold 
signal increase at TACS-1. (d), (e) Example of TACS-2, showing straightened (taut) collagen fibers stretched around and con-
straining an expanded epithelial tumor volume. At regions of TACS-2, quantitative analysis [27] of fiber angles relative to the 
tumor boundary shows a distribution of fibers around 0° that correlates to non-invading regions of tumor cells. (f) Example of 
TACS-3, showing radially aligned collagen fibers, reorganized by tumor cells, at regions of tumor cell invasion. At regions of 
TACS-3, quantitative analysis [27] of fiber angles relative to the tumor boundary shows a distribution of fibers around 90° that 
correlates with local invasion of tumor cells.BMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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around 0° was associated with non-invading regions of
the tumor [27].
In comparing tumors in the wild-type and heterozygous
Col1a1tmJae backgrounds carrying the MMTV-PyVT trans-
gene, we identified critical differences in the temporal
progression in density-associated tumors (Figure 5). At 8
weeks of age, TACS-1 formation in wild-type tumors (Fig-
ure 5a) was not yet well developed, and tumors were pri-
marily non-invasive with collagen fibers distributed
around 0° (Figure 5b and 5c). In contrast, collagen-dense
tumors (PyVT/Col1a1) displayed more developed TACS-1
with increased collagen signal and more straightened fib-
ers, indicating early progression to TACS-2 (Figure 5a)
and some regions of TACS-3 (Figures 5b and 5c). Dense
tissues (PyVT/Col1a1) began to show regions of local
invasion at 8 weeks (Figure 5b-ii; highlighted with and
arrowhead) corresponding to an increased frequency of
reorganized collagen fibers with a peak realignment near
90° (Figure 5c). By 10 weeks of age this difference was
enhanced. While tumors from PyVT/wt animals were still
largely non-invasive, tumors that arose in collagen-dense
tissues continued to have more collagen signal, enhanced
realignment to TACS-3, and increased local invasion (Fig-
ures 5b and 5c), supporting histological findings shown
in Figure 2e. Moreover, this shift in the temporal onset of
TACS-3 to an earlier occurrence in collagen-dense tumors
indicates the more advanced and invasive state of these
tumors.
Spectral-lifetime imaging of the tumor-stromal interaction 
suggests a metabolic signature associated with invasion
In concert with changes in the alignment of stromal colla-
gen and increased local invasion, higher cellular autoflu-
orescence intensity was observed in stromal cells and
invading tumor cells when compared with cells in the pri-
mary tumor mass (Figures 5 and 6). To examine these pro-
gression-associated changes in more detail, we imaged the
tumors with multiphoton FLIM and SLIM [32,33,39].
Using SLIM, the peak cellular emission was detected at
530 nm. Hence, the spectral properties, or 'fingerprint', of
the endogenous cellular fluorophore identified it as flavin
adenine dinucleotide (FAD), and not nicotinamide ade-
nine dinucleotide (NADH) or tryptophan [40], and con-
firmed the presence of collagen (Figure 6a and Additional
file 1), which has a theoretical zero fluorescence lifetime
that is experimentally equal to the system signal response
due to background noise (that is, 100 ns (blue) in Figure
6b).
Exploiting cellular FAD as an endogenous biomarker to
visualize cells, we further explored the difference in FAD
signal between stromal and tumor cells, using FLIM. Dif-
ferences in the fluorescence lifetime of FAD between pri-
mary tumor cells and stromal cells were color mapped
(Figure 6b) and quantified (Figure 6c). Stromal cells pos-
sessed a higher second component (τ2) and weighted
mean (τm) of the fluorescent lifetime, allowing stromal
cells to be easily differentiated from epithelial tumor cells
(Figure 6b and 6c).
Interestingly, invading cells displayed a fluorescent inten-
sity more closely resembling stromal cells than cells from
the primary tumor mass (Figure 7a and 7b). Consistent
with this finding, changes in fluorescent intensity and flu-
orescent lifetimes of NADH and tryptophan have also
been associated with cells of differing metastatic potential
[41]. Because invading tumor cells commonly de-differ-
entiate, it is possible that shifts in the fluorescent lifetime
may be indicative of fundamental changes in cells associ-
ated with invasion and metastasis. In fact, a metabolic sig-
nature of higher FAD fluorescent intensity was observed
in cells near invading regions when compared with non-
invading regions (Figure 7a) while invading tumor cells
showed a longer FAD fluorescent lifetime (the right panel
in Figure 7b), having higher first (τ1), second (τ2), and
weighted mean (τm) lifetime components (Figure 7c), and
could be differentiated from stromal cells and cells in the
primary tumor mass. Furthermore, examination of τ2 val-
ues indicates a progressive increase in lifetimes from cells
within the tumor mass to invading cells to stromal cells
(Figure 7d) supporting the idea of a fundamental change
to invading cancer cells.
In addition to identifying key differences in measurable
fluorescent intensity and lifetime associated with invad-
ing cells, FLIM analysis confirmed results shown in Figure
4 demonstrating a shift towards TACS-3 and increased
local invasion with higher collagen density (see Figure
7b). Invading cells associated with TACS-3 could be
clearly differentiated in collagen-dense tissues (the right
panel in Figure 7b) while PyVT/wt tumors (the left panel
in Figure 7b) were not highly invasive at this stage (week
10).
Discussion
Collagen density and tumor formation and progression
Although the increased risk for breast carcinoma associ-
ated with collagen-dense breast tissue has been described
[1-3], a causal link between increased stromal collagen
and increased breast carcinoma has not been previously
established. Moreover, little is known about the molecu-
lar mechanisms underlying increased collagen deposition
and its influence on the interactions between stromal col-
lagen, fibroblasts, and epithelial cells, or how increased
collagen affects tumorigenesis and tumor cell phenotype.
This is due in large part to the fact that no animal model
system had previously existed to study these phenomena
in vivo. Herein we demonstrate that mice with increased
stromal collagen have increased mammary tumors thatBMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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Increased progression of tumor-associated collagen signatures and increased local invasion with high collagen density Figure 5
Increased progression of tumor-associated collagen signatures and increased local invasion with high collagen 
density. (a) TACS-1 in 8-week-old normal (wild-type; (i), (ii)) and collagen-dense (col1a1; (iii), (iv)) tumors showing more 
developed TACS-1 associated with density (early transition between TACS-1 and -2) while showing very early TACS-1 forma-
tion in wild-type tumors (shown with yellow arrowheads; white arrowhead indicates a TACS-1 region that is not shown since 
it is out of the focal plane). The displayed tumor regions ((ii) and (iv)) are at a ∆z = 40 µm from collagen signatures ((i) and (iii)). 
Note the increased endogenous cellular autofluorescence associated with tumor cells in collagen-dense tissues when PyVT/wt 
(ii) and PyVT/Col1a1 (iv) tumors were imaged sequentially at the same power settings ((ii) versus (iv)). Representative of n = 4 
pairs of tumors. (b) Tumors were imaged and MPE (pseudo-colored red) and SHG (pseudo-colored green) signals were sepa-
rated. At 8 weeks tumors showed early TACS-3 regions and some local invasion in collagen-dense tumors (ii) while PyVT/wt 
tumors (i) were still primarily bound by collagen (TACS-2) and non-invasive. At 10 weeks, tumors from dense tissues (iv) dis-
played further regions of TACS-3 progression and an invasive phenotype, compared to control tissues (iii) that were largely 
non-invasive and had little collagen reorganization. Representative of n ≥ 6 tumors from each background. (c) Quantitative 
analysis of collagen fiber angles relative to the tumor boundary for 8-week (top) and 10-week (bottom) old animals. PyVT/wt 
animals displayed little TACS-3 and are primarily non-invasive with only 23% (8 weeks) and 24% (10 weeks) of their fibrils hav-
ing angles outside of the TACS-2 distribution around 0° (that is less than -15° or more than 15°). In contrast PyVT/Col1a1 
tumors were more invasive, possessing a broader fiber distribution and some regions of TACS-3 (distribution around 90°), 
with 46% and 51% of the fibrils distributed outside of the TACS-2 distribution (0°) at 8 weeks and 10 weeks, respectively 
(*indicates that the number of events associated with TACS-3/invasion (75° to 105°) was significantly greater). Calculated from 
at least 185 of tumor regions from at least 6 separate tumors. All scale bars are 25 µm.BMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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are more invasive and metastatic, and thus provide a
causal link between stromal density and carcinoma pro-
gression, consistent with reports of human breast carci-
noma risk.
In this system, increased collagen density is the initial
event, promoting tumor initiation and metastasis. This
may be the result of two likely mechanisms (Figure 8),
both of which follow the increase in collagen density (that
is, increasing collagen is the initial event in our system).
The first mechanism is that increased breast density is
associated with a stiffer extracellular matrix resulting in
high local mechanical loads and higher resistance to cel-
lular contractility for breast epithelial cells. Such changes
in the physical microenvironment has been shown to alter
focal adhesion and Rho GTPase signaling, resulting in
increased proliferation and a more transformed pheno-
type [24,25]. A second, and more indirect mechanism,
may be the influence of increased stromal collagen on
mammary fibroblasts that in turn influence epithelial
cells. Stromal fibroblasts can regulate epithelial cells in
part through secretion of specific soluble growth factors
and chemokines [20,42-44]. For instance, TGF-β has been
associated with reactive stroma, fibrosis, and epithelial
cell invasion [45], while numerous studies indicate that
the epidermal growth factor (for example, EGFR, HER-2/
neu/ErbB2, ErbB3, and so on), insulin-like growth factor
(for example, IGF-I, IGFBP3, and so on), and hepatocyte
growth/scatter factor (HGF/SF, c-Met) systems are impor-
tant not only in the normal mammary gland but also dur-
ing tumorigenesis and metastasis [44,46-49].
Furthermore, the IGF family has been implicated in asso-
ciation with dense breast tissue [14,50,51] with both local
[14] and circulating [50,51] levels of IGF-I positively cor-
FLIM an SLIM analysis of mammary tumors Figure 6
FLIM an SLIM analysis of mammary tumors. (a) Multiphoton spectral lifetime imaging microscopy (SLIM) analysis of the 
emission spectrum from endogenous fluorescence resulting from excitation at 890 nm. The emission signals were separated by 
10 nm spectral steps over 16 channels (10 channels are displayed) and the photons collected in each channel used to generate 
fluorescence lifetime images and signals for each channel plotted with SLIM-Plotter (shown). Emission from collagen (at half of 
the input wavelength) showed a very strong and sharp signal with a no appreciable decay (lifetime) confirming the SHG nature 
of the collagen signal (top). Emission spectra of endogenous fluorescence from tumor and stromal cells showed that the only 
substantial emission signal is at 530 nm, indicating that the source of the autofluorescence signal is FAD, with lifetime values 
from the 530 channel matching values obtained with fluorescence lifetime imaging microscopy (FLIM). (b) Multiphoton inten-
sity and FLIM images of the stroma near a tumor (top) and the tumor and stromal components (bottom) from wild-type 
tumors showing the utility of FLIM to image tumor cells, stromal cells, and extracellular matrix components. Note the 
increased intensity and fluorescent lifetimes of stromal cells (quantified in (c)) and the low lifetime of collagen (matching system 
response, that is, no actual lifetime/color mapping toward blue). The color map in (b) represents the weighted average of the 
two-term model components (τm = (a1τ1 + a2τ2)/(a1 + a2)) using the equation shown in (c). (c) Quantitative analysis of fluores-
cent lifetime components from tumor and stromal (subscript s) cells using the equation shown. Note the increase in the sec-
ond (long) component and weighted mean component (see the equation above) for stromal cells when compared with cells 
from the primary tumor mass. Note that at least 30 measurements per tumor image from 4 independent tumors were used to 
calculate lifetime values for tumor cells in the primary tumor mass while at least 6 measurements per tumor image from 4 inde-
pendent tumors were used for stromal cells. *Indicates a statistically significant (p < 0.05) difference following analysis with 
one-way analysis of variance (ANOVA) with a post-hoc Tukey-Kramer test.BMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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related with breast tissue density. In fact, both of these
mechanisms are plausible and are likely to be acting in
concert with one another to produce fundamental
changes in both the breast epithelial and stromal cells.
Since both adhesion-mediated and growth factor-medi-
ated signaling pathways are often interrelated [52-57],
understanding each of these possible mechanisms and
their convergence is likely to be of great importance to
understanding breast tissue density-related carcinoma.
However, the possibility that altered matrix remodeling
associated with the Col1a1 model is playing a role also
warrants consideration. However, in theory, a significant
defect in matrix remodeling should inhibit tumor progres-
sion, and the fraction of collagen that is collagenase-resist-
ant can be degraded/remodeled at a second site by the
rodent collagenase and other proteases that are expressed
by tumor and tumor-associated cells. Hence, while limita-
tions of the model must be taken into account when con-
sidering the presented data, it appears unlikely that a
defect in matrix remodeling associated with the use of the
Col1a1 model is causal for the increases in tumor forma-
tion and progression observed in this study.
Collagen signatures and local invasion
In a previous study we described the use of collagen align-
ment to quantify local invasion with the level of TACS-2
(alignment tangential to the tumor boundary at a 0°
angle) and TACS-3 (alignment radial to the tumor bound-
ary at an angle of 90°) providing a novel quantitative
assessment of tumor progression [27]. In this study, the
analysis of collagen radial alignment in samples from 8-
and 10-week tumors demonstrates a transition from
TACS-2 to TACS-3. We observe a broad distribution of
Fluorescence lifetime imaging microscopy analysis of invading tumor cells Figure 7
Fluorescence lifetime imaging microscopy analysis of invading tumor cells. (a) Intensity and fluorescence lifetime 
imaging microscopy (FLIM) images of cells away from and near invasive TACS-3 regions showing increased fluorescent intensity 
and lifetime near invasive regions (left side of images). (b) FLIM images of tumors from 10-week-old PyVT/wt and PyVT/Col1a1 
animals confirming the increased TACS-3 for collagen-dense tumors shown in Figure 5. (c) Increased fluorescent lifetimes for 
invading cells. Like stromal cells the second (long) and mean components are increased in invading cells. However, the short 
component is also increased in invading cells when compared to cells in the primary tumor mass. Note, 45 measurements for 
cells within the primary tumor mass and 45 measurements for invading cells adjacent to the tumor primary tumor mass were 
used to calculate lifetime values. (d) The second (long) component from cells within the primary tumor mass, invading tumor 
cells, and stromal cells showing a progressive increase as cells move from a primary epithelial tumor phenotype to a more 
migratory phenotype. *Indicates a statistically significant (p < 0.05) difference following analysis with one-way analysis of vari-
ance (ANOVA) with a post-hoc Tukey-Kramer test.BMC Medicine 2008, 6:11 http://www.biomedcentral.com/1741-7015/6/11
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fiber angles away from zero but not yet tightly grouped as
late-stage tumor at the radial alignment (90°) associated
with the high degree of local invasion previously reported
for 15-week tumors [27]. This result suggests that the
move toward invasive behavior is a transitional process
increasing with time. We find that tumor cells in collagen-
dense tumors are not only more invasive and metastatic in
vivo, but were also more invasive and migratory in vitro
(Figure 3b and 3c), indicating that the increased invasive-
ness is not only the result of earlier tumorigenesis that had
more time to progress, but also due to tumor cells that are
fundamentally more invasive because they arose within
collagen-dense tissues. This finding suggests that cellular
behavior is altered by epigenetic changes signaled from
the collagen-dense stroma, consistent with findings that
increased collagen density alters epithelial cell signaling
and behavior in vitro [25].
FAD and local invasion
Interestingly, we measured an increase in the fluorescence
lifetime for the metabolite FAD associated with invading
cells. While this information provides a valuable biomar-
ker for use with an optical biopsy, the biological relevance
of this finding is not well understood. It is known that
transformed cells often undergo increased glycolysis in
the cytosol, a phenomena known as the Warburg effect
[58], and that the fluorescent lifetimes of NADH and FAD,
and in particular the redox ratio of these two metabolites,
is altered in transformed cells [59]. Of interest, Skala and
co-workers [59] recently reported an increase in the τ1
component of the FAD lifetime in precancerous cells
when compared with normal epithelium. In the current
study we compare non-invasive transformed cells with
invading cells, and as such we speculate that the alteration
in FAD state seen in transformation may become increas-
ingly mis-regulated in the more metastatic population of
transformed cells. Furthermore, the biological implica-
tions of the increased FAD intensity and fluorescent life-
time may be found in the possibility that increased
glycolysis is increasing levels of NADH, a known regulator
of transcription [60], and resulting in more lactic acid pro-
duction [61] with less pyruvate entering into the citric acid
cycle and, as a consequence, less FAD being reduced to
FADH2. Moreover, it has also been reported that the fluo-
rescence lifetime of FAD can decrease due to quenching
from NAD+, other molecular interactions, or environ-
mental conditions [62,63], and thus the increased fluores-
cence lifetime of FAD could also be indicative of less
available NAD+, particularly in the cytosol, and other
unknown changes in FAD binding and localization.
Hence, the biological implications of altered FAD inten-
sity and fluorescence lifetime remain elusive. However,
our results provide evidence that changes in FAD signals
can be found within a more invasive subpopulation of
carcinoma cells and as such understanding the regulatory
mechanisms associated with these observations may pro-
vide great insight into tumor cell metastasis.
Conclusion
In summary, increased collagen density increases tumori-
genesis, local invasion, and metastasis, causally linking
increased stromal collagen to tumor formation and pro-
gression. Imaging with combined MPE and SHG in
tumors allows visualization of cellular autofluorescence
and defined collagen structures that identify key differ-
ences associated with high collagen density and may pro-
vide useful diagnostic tools to rapidly assess fresh tissue
biopsies. Furthermore, imaging live tissues with FLIM and
SLIM confirms results obtained with MPE/SHG and iden-
tifies significant differences in fluorescence lifetimes that
are indicative of invasive cells. Thus, FLIM and SLIM serve
as powerful tools to evaluate the invasiveness of tumor
cells in mammary tissues. Given the significant findings
associated with high breast tissue density and the now
available utility of a mouse model for breast tissue den-
sity, fundamental questions regarding the molecular
mechanisms associated with breast tissue density-related
carcinoma can now be further addressed in vivo.
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